Stay up to date with the latest in innovative, digitally enabled solutions.

With a focus on positive outcomes through clinically validated methods and digital tools, we help today’s diverse workplace thrive by improving the lives of their members and families.

  • Filter Resources

  • Clear All

  • Topic

  • Resource Type

  • Industry

With EAP Plus, utilization rate increased from 18% to 47%

See how The Ōnin Group improved program engagement with Uprise Health.

Download Case Study
Uprise Health Icon
Blog 2 min

Abuse of Reformulated OPANA® ER: early findings from NAVIPPRO® data

Theresa A. Cassidy, MPH, Emily C. McNaughton, MPH , Kimberly…

Learn More
Uprise Health Icon
Blog 2 min

Differences in rates of abuse and routes of administration for original and reformulated extended-release oxycodone among individuals assessed for substance abuse

S.F. Butler, H. Chilcoat, T.A. Cassidy, R.A. Black, C. Landau,…

Learn More
Uprise Health Icon
Blog 2 min

Change in prescription opioid abuse after introduction of an abuse deterrent formulation

Theresa A. Cassidy, MPH, Emily C. McNaughton, MPH , Stephen…

Learn More
Uprise Health Icon
Blog 2 min

Effects of reformulated OxyContin® among patients assessed for substance abuse treatment in the NAVIPPRO sentinel surveillance network

Ryan Black, Paul Coplan, Theresa A. Cassidy, Howard Chilcoat, Simon…

Learn More
Uprise Health Icon
Blog 2 min

Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers

Based on a recent study, our team has published an…

Learn More
Uprise Health Icon
Blog 1 min

Initial Validation of a Computer-Administered Addiction Severity Index: The ASI-MV

Based on a recent study, our team has published an…

Learn More

Barriers to care have reached critical levels

This flipbook can help you better understand the biggest barriers and how to respond.

Learn More